KETEK by Sanofi is clinical pharmacology pharmacokinetics absorption following oral administration, telithromycin reached maximal concentration at about 1 hour (0. Approved for community-acquired pneumonia (of mild to moderate severity) due to streptococcus pneumoniae, (including multi-drug resistant isolates [mdrsp mdrsp, multi-drug resistant streptococcus pneumoniae includes isolates known and 2 more indications. First approved in 2004.
Drug data last refreshed 9h ago · AI intelligence enriched 6d ago
KETEK (telithromycin) is a ketolide antibiotic indicated for community-acquired pneumonia of mild to moderate severity caused by Streptococcus pneumoniae, including multi-drug resistant isolates. It is administered orally as an 800-mg once-daily tablet and works by inhibiting bacterial protein synthesis through binding to the ribosome.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating reduced team expansion and focus on transition planning.
CLINICAL PHARMACOLOGY Pharmacokinetics Absorption Following oral administration, telithromycin reached maximal concentration at about 1 hour (0.5 – 4 hours). It has an absolute bioavailability of 57% in both young and elderly subjects. The rate and extent of absorption are unaffected by food…
Worked on KETEK at Sanofi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Ketek in CAP / AECB in Ambulatory Adult Patients
AMS VS MOXI Ketek vs Avelox in AMS
KETEK offers limited career growth due to its LOE Approaching status and zero linked job postings, indicating a contracting team. Professionals should evaluate this role as a short-term assignment with transition planning rather than a long-term career platform.